logo
logo

Gtcr Announces Strategic Investment In Resonetics By Carlyle

Gtcr Announces Strategic Investment In Resonetics By Carlyle

12/03/21, 8:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgchicago
GTCR, a leading private equity firm, announced today that its portfolio company, Resonetics (or the "Company") has sold a minority equity stake to funds affiliated with global investment firm Carlyle (NASDAQ: CG), valuing the Company at approximately $2.25 billion. Carlyle will join GTCR as a meaningful shareholder in Resonetics as a result of the transaction.

Company Info

Company
Resonetics
Location
chicago, illinois, united states
Additional Info
Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the life sciences industry. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, metal fabrication, and fiber optic sensors. With nine Lightspeed Application Development Labs located strategically to serve medical device companies around the world, Resonetics is built on a foundation of quality, speed, and innovation to deliver best-in-class value with a customer-centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, Israel, Switzerland, and Canada. For more information, please visit www.resonetics.com.